Small airway dysfunction in chronic hypersensitivity pneumonitis

被引:12
|
作者
Guerrero Zuniga, Selene [1 ]
Sanchez Hernandez, Julia [1 ]
Mateos Toledo, Heidegger [2 ]
Mejia Avila, Mayra [2 ]
Gochicoa-Rangel, Laura [1 ]
Miguel Reyes, Jose Luis [3 ]
Selman, Moises [4 ]
Torre-Bouscoulet, Luis [1 ,4 ]
机构
[1] Natl Inst Resp Dis, Dept Resp Physiol, Mexico City, DF, Mexico
[2] Natl Inst Resp Dis, Interstitial Lung Dis Clin, Mexico City, DF, Mexico
[3] Natl Inst Resp Dis, Asthma Clin, Mexico City, DF, Mexico
[4] Natl Inst Resp Dis, Res Unit, Mexico City, DF, Mexico
关键词
bird fancier's lung; hypersensitivity pneumonitis; interstitial lung disease; pulmonary function test; PIGEON-BREEDERS DISEASE; PULMONARY-FIBROSIS; LUNG-DISEASE; STANDARDIZATION; DIAGNOSIS; STATEMENT; WASHOUT;
D O I
10.1111/resp.13124
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective: Lung biopsies from patients with hypersensitivity pneumonitis (HP) have demonstrated small airway (SA) involvement, but there is no information concerning SA function in HP, and it is unknown whether pharmacological treatment could modify its function. SA function in patients with chronic HP using ultrasonic pneumography (UPG) and impulse oscillometry (IOS) was explored. We also compared initial results with those obtained after 4 weeks of standardized treatment with azathioprine and prednisone. Methods: The study group consisted of adults with recent diagnoses of HP. All patients completed UPG, IOS, spirometry, body plethysmography, single-breath carbon monoxide diffusing capacity (DLCO) and the 6min walk test (6MWT). The fraction of exhaled nitric oxide (FENO) was obtained to assess eosinophilic airway inflammation. Measurements were taken at diagnosis and after 4 weeks of treatment. Results: A total of 20 consecutive patients (16 women) with chronic HP participated in the study. Median age was 50 years (interquartile range (IQR): 42-54). At diagnosis, the UPG phase 3 slope was abnormally high, consistent with maldistribution of ventilation. For IOS, all patients had low reactance at 5 Hz (X5) and elevated reactance area (AX) reflecting low compliance, and only eight (40%) patients had elevated R5 (resistance at 5 Hz (total)) and R5-20 (resistance at 5 Hz-resistance at 20 Hz (peripheral)) attributed to SA resistance. In contrast, FENO parameters were within normal limits. After treatment, forced vital capacity (FVC), the 6-min walk distance and the distribution of ventilation showed significant improvement, although DLCO did not. Conclusion: Patients with chronic HP have SA abnormalities that are partially revealed by the UPG and IOS tests. Lung volumes, but not gas exchange, improved after treatment with azathioprine and prednisone.
引用
收藏
页码:1637 / 1642
页数:6
相关论文
共 50 条
  • [41] Impact of Azathioprine use in chronic hypersensitivity pneumonitis patients
    Alexandre, Andre Terras
    Martins, Natalia
    Raimundo, Sara
    Melo, Natalia
    Mota, Patricia Catetano
    Novais e Bastos, Helder
    Pereira, Jose Miguel
    Cunha, Rui
    Guimaraes, Susana
    Moura, Conceicao Souto
    Morais, Antonio
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 60
  • [42] Long-term outcomes in chronic hypersensitivity pneumonitis
    Ojanguren, Inigo
    Morell, Ferran
    Ramon, Maria-Antonia
    Villar, Ana
    Romero, Christian
    Cruz, Maria Jesus
    Munoz, Xavier
    ALLERGY, 2019, 74 (05) : 944 - 952
  • [43] Hypersensitivity Pneumonitis: A Comprehensive Review
    Spagnolo, P.
    Rossi, G.
    Cavazza, A.
    Bonifazi, M.
    Paladini, I
    Bonella, F.
    Sverzellati, N.
    Costabel, U.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2015, 25 (04) : 237 - 250
  • [44] Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis An International Modified Delphi Survey
    Morisset, Julie
    Johannson, Kerri A.
    Jones, Kirk D.
    Wolters, Paul J.
    Collard, Harold R.
    Walsh, Simon L. F.
    Ley, Brett
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (08) : 1036 - 1044
  • [45] Lung Cancer in Chronic Hypersensitivity Pneumonitis
    Kuramochi, J.
    Inase, N.
    Miyazaki, Y.
    Kawachi, H.
    Takemura, T.
    Yoshizawa, Y.
    RESPIRATION, 2011, 82 (03) : 263 - 267
  • [46] Diagnosis and Treatment of Hypersensitivity Pneumonitis
    Park, Moo Suk
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2009, 52 (01): : 49 - 58
  • [47] Treatment and monitoring of hypersensitivity pneumonitis
    Miyazaki, Yasunari
    Tsutsui, Toshiharu
    Inase, Naohiko
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (09) : 953 - 962
  • [48] Hypersensitivity Pneumonitis: A Silent Epidemic?
    Selvan, Kavitha
    Lee, Cathryn T.
    CURRENT PULMONOLOGY REPORTS, 2024, 13 (03) : 248 - 255
  • [49] Rituximab for the treatment of chronic hypersensitivity pneumonitis
    Ojanguren, Inigo
    Villar, Ana
    Antonia Ramon, Maria
    Jesus Cruz, Maria
    Munoz, Xavier
    Morell, Ferran
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [50] Hypersensitivity pneumonitis
    Costabel, Ulrich
    Miyazaki, Yasunari
    Pardo, Annie
    Koschel, Dirk
    Bonella, Francesco
    Spagnolo, Paolo
    Guzman, Josune
    Ryerson, Christopher J.
    Selman, Moises
    NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)